Search results for "continuous"

Article CDMOs Driving Emerging Bio/Pharma Success
This continuous funding streak is nearly twice as long as is typical for emerging bio/pharma companies. A number of factors have contributed to the explosion in funding for emerging bio/pharma …

Article CoAs Help Secure the Supply Chain
CoAs Help Secure the Supply Chain Certificates of analysis can be used to monitor the reliability of products and their suppliers. By Susan J. Schniepp, distinguished fellow at…

Article Full Single-Use Downstream Process? Not Any Time Soon.
Single-use technologies (SUTs) are here to stay. But where we see full single-use upstream processes, downstream is often a hybrid solution. Here’s why SUTs will not completely replace reuse systems…

Article Industry Adoption of Single-Use Systems Remains Low
Single-use technologies are starting to gain ground as capacity needs change, but industrywide adoption remains low. By Feliza Mirasol zli…

Article Preclinical Evaluation of Product Related Impurities and Variants
Preclinical Evaluation of Product Related Impurities and Variants The approaches for sample preparation of preclinical evaluation of safety and efficacy are addressed taking into consideration the s…

Resource CCP Summit
Three-day summit on commercializing continuous processing in pharma. Jan 30-Feb 1, Boston, MA

Article Manufacturing Standards Key to Advancing Cellular and Gene Therapies
Manufacturing Standards Key to Advancing Cellular and Gene Therapies FDA works with industry on strategies for assuring high-quality regenerative medicines. By Jill Wechsler …

Article Avoiding Investigational Failures and Discrepancies
Avoiding Investigational Failures and Discrepancies Investigational failures and discrepancies can be avoided through the proper execution and documentation of investigations. By Walt Murray,…

Article Contract Manufacturing Through the Years
Developments in manufacturing technologies such as vastly improved yields for biologics, single-use systems, and continuous processing simultaneously require CDMOs to invest in new technologies while …

Article Managing Risk in Biomanufacturing
With patients’ lives dependent on a continuous supply of high-quality drugs and vaccines, it is essential to have consistency within the industry on how to manage risks. Today’s business environment r…

Previous PageNext Page